Philips Sells Emergency Care Business
Royal Philips has signed an agreement to sell its Emergency Care business -- which includes AEDs, advanced life support defibrillators, and prehospital monitoring solutions -- to Bridgefield Capital.
Royal Philips has signed an agreement to sell its Emergency Care business -- which includes AEDs, advanced life support defibrillators, and prehospital monitoring solutions -- to Bridgefield Capital.
Royal Philips has signed an agreement to sell its Emergency Care business — which includes AEDs, advanced life support defibrillators, and prehospital monitoring solutions — to Bridgefield Capital.
Read MoreRespiratory failure due to hypoxemia and/or hypercapnia calls for oxygen therapy, positive pressure support, and possibly ventilatory support. Care for these patients may escalate and require higher flow, FiO2, and more complex devices and intensive monitoring.
Read MoreSome patients who have been impacted by Lincare and Philips Respironics have joined forces with these corporations to lobby for an end to Medicare’s competitive bidding process for oxygen and to make liquid oxygen available.
Read MoreIn hospital settings, the terms “NIV” and “BiPAP” are often used synonymously. However, when patients are being discharged to home care, the exact terminology used by physicians is essential in order to prescribe the precise therapy.
Read MoreA report from ProPublica says that Lincare was supposed to supply the most ailing patients with new CPAPs but instead diverted the devices to new customers who would deliver greater profits for the company.
Read MorePhilips has issued updated use instructions for several ventilator models following an FDA Class I recall due to risks of aerosol deposits accumulating on internal flow sensors when in-line nebulizers are used.
Read MoreThe correction addresses potential risks of aerosol buildup on ventilator flow sensors when using in-line nebulizers.
Read MorePhilips Respironics has issued a software update and revised user instructions for its Trilogy ventilators to address previously reported and new safety risks.
Read MorePhilips Respironics has issued a recall for its OmniLab Advanced+ ventilators due to an alarm failure that can lead to therapy interruption or loss of ventilation.
Read MorePhilips Respironics updated the use instructions for BiPAP V30, A30, and A40 ventilators due to potential therapy interruptions and serious health risks.
Read MorePhilips Respironics Inc is recalling its Trilogy Evo continuous ventilators due to a possible software-related power malfunction.
Read MoreThe company anticipates the settlement will resolve all personal injury and medical monitoring claims related to its June 2021 recall.
Read MoreThe decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
Read MoreThe FDA issued an update on the June 2021 recall of Philips Respironics ventilators, BiPAP and CPAP devices for the period of July 1, 2023 through September 30, 2023.
Read MoreGerald E. McGinnis, founder of Respironics and creator of the first CPAP machine to treat sleep apnea, died on Jan 25 at age 89.
Read MoreUntil the requirements of the consent decree are met, Philips Respironics will not sell new CPAP, BiPAP, or other respiratory care devices in the US.
Read MorePhilips Respironics will end the sale of “hospital ventilation products, certain home ventilation products, portable and stationary oxygen concentrators and sleep diagnostic products,” according to a company announcement.
Read MoreMedical providers and patients who leased, rented, or purchased recalled Philips CPAPs, BiPAPs, or ventilators—as well as payers who reimbursed recalled devices—can now file a claim for a share in the company’s $479 million settlement deal.
Read MoreThe FDA received over 270 reports related to thermal issues such as fire, smoke, burns, and other signs of overheating while patients are using Philips DreamStation 2 CPAP machines.
Read MoreMillions of people were impacted by the 2021 recall of Philips breathing machines. Here are nine of their stories.
Read MorePhilips argued in court that its US subsidiary should be responsible for damages caused by its CPAP machines and ventilators, but patients’ attorneys say safety decisions were made at the Dutch company’s highest levels.
Read MoreThe ventilators contain power management printed circuit board assemblies that were distributed by a third-party warehouse and do not meet ventilator standards, per a safety communication.
Read MorePhilips Respironics says it plans to conduct additional testing on certain respiratory care and sleep devices involved in its June 2021 recall at the request of the FDA.
Read MoreThe FDA has requested Philips conduct additional testing on its recalled CPAP, BiPAP, and ventilator devices, calling testing to date inadequate to fully evaluate the risks posed to users.
Read More